Clinical trials data
Symbol Coding in dementia and Alzheimer's trials: 117 registered studies
Every registered dementia and Alzheimer's disease study on ClinicalTrials.gov that names Symbol Coding in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered dementia and Alzheimer's disease studies name it in an outcome measure
- 117
- Name it in a primary outcome, 35%
- 41 of 117
Tests named in the same studies
- 1
Trail Making Test51 studies, 20 as a primary outcome
- 2
Category Fluency42 studies, 17 as a primary outcome
- 3
Verbal Fluency42 studies, 16 as a primary outcome
- 4
Verbal Learning37 studies, 20 as a primary outcome
- 5
Digit Span Test36 studies, 13 as a primary outcome
- 6
Short Story Recall26 studies, 13 as a primary outcome
- 7
Selective Reminding Task24 studies, 9 as a primary outcome
- 8
Stroop Color-Word Test23 studies, 13 as a primary outcome
- 9
Picture Naming Test14 studies, 8 as a primary outcome
- 10
Complex Figure Copy and Recall12 studies, 6 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 3 | 0 |
| 2008 | 1 | 0 |
| 2009 | 2 | 1 |
| 2010 | 3 | 1 |
| 2011 | 2 | 2 |
| 2012 | 6 | 4 |
| 2013 | 4 | 1 |
| 2014 | 3 | 2 |
| 2015 | 2 | 0 |
| 2016 | 4 | 0 |
| 2017 | 5 | 3 |
| 2018 | 9 | 4 |
| 2019 | 11 | 5 |
| 2020 | 5 | 1 |
| 2021 | 14 | 6 |
| 2022 | 5 | 2 |
| 2023 | 12 | 4 |
| 2024 | 6 | 3 |
| 2025 | 9 | 1 |
| 2026 | 7 | 0 |
Phases and study sizes
By phase
- Early phase 12 studies, 1 as a primary outcome
- Phase 12 studies, 0 as a primary outcome
- Phase 1/26 studies, 1 as a primary outcome
- Phase 224 studies, 8 as a primary outcome
- Phase 2/34 studies, 2 as a primary outcome
- Phase 314 studies, 3 as a primary outcome
- Phase 44 studies, 1 as a primary outcome
- Not applicable42 studies, 13 as a primary outcome
- Observational19 studies, 12 as a primary outcome
Participants per study
- Phase 2116 median, 47 to 205
- Phase 3802 median, 203 to 1,061
- Not applicable83 median, 49 to 155
- Observational400 median, 114 to 750
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 22 | 116 | 47 to 205 |
| Phase 3 | 14 | 802 | 203 to 1,061 |
| Not applicable | 42 | 83 | 49 to 155 |
| Observational | 17 | 400 | 114 to 750 |
When dementia and Alzheimer's trials measure it
Latest time point of each outcome
- Within a day9 outcomes, 4 as a primary outcome
- Up to 4 weeks13 outcomes, 1 as a primary outcome
- 1 to 3 months15 outcomes, 5 as a primary outcome
- 3 to 6 months23 outcomes, 9 as a primary outcome
- 6 to 12 months20 outcomes, 6 as a primary outcome
- 1 to 2 years13 outcomes, 4 as a primary outcome
- Over 2 years19 outcomes, 9 as a primary outcome
- No duration given5 outcomes, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
112 of the 117 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting17 studies, 4 as a primary outcome
- Not yet recruiting6 studies, 0 as a primary outcome
- Active, not recruiting6 studies, 4 as a primary outcome
- Completed58 studies, 21 as a primary outcome
- Stopped early15 studies, 6 as a primary outcome
- Status unknown15 studies, 6 as a primary outcome
What they test
- Behavioral20 studies, 9 as a primary outcome
- Drug48 studies, 12 as a primary outcome
- Device15 studies, 4 as a primary outcome
- Dietary supplement4 studies, 1 as a primary outcome
- Procedure3 studies, 1 as a primary outcome
- Diagnostic test3 studies, 1 as a primary outcome
- Biological4 studies, 0 as a primary outcome
- Radiation1 studies, 0 as a primary outcome
- Combination product1 studies, 1 as a primary outcome
- Genetic1 studies, 0 as a primary outcome
- Other23 studies, 10 as a primary outcome
- None given12 studies, 8 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States60 studies, 24 as a primary outcome
- United Kingdom15 studies, 8 as a primary outcome
- Australia12 studies, 4 as a primary outcome
- France12 studies, 4 as a primary outcome
- Italy11 studies, 3 as a primary outcome
- Spain11 studies, 4 as a primary outcome
- Canada10 studies, 4 as a primary outcome
- China9 studies, 3 as a primary outcome
- Germany9 studies, 3 as a primary outcome
- Brazil8 studies, 1 as a primary outcome
- Japan8 studies, 2 as a primary outcome
- Netherlands7 studies, 1 as a primary outcome
48 countries in all. A study with sites in several counts in each; 8 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed dementia and Alzheimer's disease studies that name Symbol Coding: 36 of 58, 62%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed dementia and Alzheimer's disease studies that name Symbol Coding | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 11, 19% | 776, 10% |
| Results on ClinicalTrials.gov only | 8, 14% | 1,139, 14% |
| A results paper only | 17, 29% | 1,711, 22% |
| Neither | 22, 38% | 4,327, 54% |
The 117 studies
117 studies match. 41 name Symbol Coding in a primary outcome. Median size 114 participants. Median time to the primary outcome: 6 months.
Loading 117 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 3 | 0 |
| 2008 | 1 | 0 |
| 2009 | 2 | 1 |
| 2010 | 3 | 1 |
| 2011 | 2 | 2 |
| 2012 | 6 | 4 |
| 2013 | 4 | 1 |
| 2014 | 3 | 2 |
| 2015 | 2 | 0 |
| 2016 | 4 | 0 |
| 2017 | 5 | 3 |
| 2018 | 9 | 4 |
| 2019 | 11 | 5 |
| 2020 | 5 | 1 |
| 2021 | 14 | 6 |
| 2022 | 5 | 2 |
| 2023 | 12 | 4 |
| 2024 | 6 | 3 |
| 2025 | 9 | 1 |
| 2026 | 7 | 0 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 36, NIH 1, other 80. Interventional 98, observational 19.
As a primary outcomeSecondary or other outcomeSymbol Coding
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07856043 | Start2026 | PhasePhase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Cardiovascular disease | Participants18 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07842146 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07717411 | Start2026 | PhasePhase 3 | ConditionsDementia and Alzheimer's | Participants1,600 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07700615 | Start2025 | PhasePhase 4 | ConditionsDementia and Alzheimer's | Participants120 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT07664865 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants250 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07651787 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07452939 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Delirium, surgery and intensive care | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07392944 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07376135 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07241598 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants70 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07240805 | Start2027 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants60 | Lead sponsorIndustry | StatusNot yet recruiting | Library tests named
|
| NCT07233512 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants26 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07163039 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants60 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07135245 | Start2026 | PhasePhase 2 | ConditionsDementia and Alzheimer's | Participants180 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07089303 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants750 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06953167 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants600 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06832761 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants300 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06647498 | Start2024 | PhasePhase 2/3 | ConditionsDementia and Alzheimer's | Participants280 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06587763 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Brain injury and concussion, Cardiovascular disease | ParticipantsNot given | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT06538116 | Start2024 | PhasePhase 2 | ConditionsDementia and Alzheimer's | Participants304 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT06492967 | Start2021 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants1,065 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06424236 | Start2020 | PhasePhase 2/3 | ConditionsDementia and Alzheimer's | Participants73 | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT06416072 | Start2023 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants3,000 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06235840 | Start2018 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants117 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06174038 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Hearing loss | Participants150 | Lead sponsorOther | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many dementia and Alzheimer's trials use Symbol Coding?
117 registered dementia and Alzheimer's disease studies on ClinicalTrials.gov name it in an outcome measure, 41 of them in a primary outcome: 7% of the condition's 1,673 studies with a cognitive outcome, against 9% of all of them. It is the 6th most named test in dementia and Alzheimer's trials.
Which tests do dementia and Alzheimer's trials use with Symbol Coding?
The Trail Making Test (51 studies), Category Fluency (42 studies) and Verbal Fluency (42 studies).
How many participants do phase 2 dementia and Alzheimer's trials that use Symbol Coding enroll?
Half of the phase 2 studies that name it enroll 116 participants or fewer, and the middle half enroll 47 to 205. 22 of them give a size.
When do dementia and Alzheimer's trials measure Symbol Coding?
Half of the primary outcomes that name Symbol Coding are measured within 6 months of the start, and the middle half from 14 weeks to 2 years. 38 primary outcomes give a duration.
How many completed dementia and Alzheimer's trials that use Symbol Coding have reported results?
36 of the 58 completed studies that name it, 62%, have reported results: 19 posted them on ClinicalTrials.gov, 28 have a results paper linked to the registry record, and 11 did both. The other 22 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Symbol Key Game and Symbol Coding as one test family, so this page counts their studies together.
Run Symbol Coding in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.